For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| CTY-5339-A 1 Spray | Benzocaine and Tetracaine 14.0% Benzocaine, USP = 28 mg 2.0% Tetracaine Hydrochloride, USP = 4 mg Benzocaine and Tetracaine: A single application 1 spray of a combination of benzocaine 14% and tetracaine 2% with a total dose of benzocaine 28 mg and tetracaine 2 mg per spray. | 0 | None | 0 | 20 | 0 | 20 | View |
| CTY-5339-A 2 Sprays | Benzocaine and Tetracaine 14.0% Benzocaine, USP = 56 mg 2.0% Tetracaine Hydrochloride, USP = 8 mg Benzocaine and Tetracaine: A single application of 2 sprays of a combination of benzocaine 14% and tetracaine 2% with a total dose of benzocaine 28 mg and tetracaine 2 mg per spray. | 0 | None | 0 | 20 | 0 | 20 | View |
| CTY-5339-CB 1 Spray | Benzocaine only 14.0% Benzocaine, USP = 28 mg Benzocaine only: Benzocaine 14% alone 200 uL (1 spray) A single application of 1 spray of benzocaine 14% with a total dose of benzocaine 28 mg. | 0 | None | 0 | 20 | 1 | 20 | View |
| CTY-5339-CB 1 Spray + Placebo 1 Spray | Benzocaine and Placebo 14.0% Benzocaine, USP = 28 mg; 200 uL and one spray Vehicle control (no active ingredient); 200 uL A single application of 1 spray of benzocaine 14% and a single spray of placebo with a total dose of benzocaine 28 mg. | 0 | None | 0 | 20 | 0 | 20 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Feeling faint | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA (19.0) | View |